Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034896707> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2034896707 abstract "Background The trough concentration of teicoplanin should be >10 mg/L for successful treatment, although it needs to be >20 mg/L for more severe staphylococcal infections, such as endocarditis and osteomyelitis. Purpose To analyse the trough serum concentrations for teicoplanin by therapeutic drug monitoring (TDM) in current clinical practise in our hospital. Materials and Methods Descriptive, analytical, observational study involving the first determination of trough serum concentration of teicoplanin, intravenously administered, from 2010 to 2012. Results Trough serum concentrations of teicoplanin from 48 inpatients (56.3% female) were analysed. The mean age was 59.8 years (CI95%: 55.7–63.9). 58.3% of the inpatients received one single loading dose of 800 mg, the other 37.5% received 400 mg twice daily for the first day, one patient (2.1%) 400 mg twice daily for two days and another patient (2.1%) 400 mg each day. 70.8% of inpatients continued with 400 mg twice daily, 25% with 400 mg once daily and the rest with 200 mg once daily. The mean dose was 6.9 mg/kg/day (CI95%: 5.4–8.5 mg/kg/day). The number of doses received until the first determination was 4.7 (CI95%: 4.1–5.3 doses) It was observed that the 37.5% of inpatients had a trough serum concentration of teicoplanin lower than 10 mg/L, 58.3% between 10–25 mg/L and 4.2% greater than 25 mg/L. 64.3% of the patients received 400 mg once daily and 26.5% had doses of 400 mg twice daily and had concentrations lower than 10 mg/L. All patients with concentrations lower than 10 mg/L were readjusted in their dose and frequency to reach serum trough concentrations greater than 10 mg/L, in steady-state. Conclusions We found out one problem in our setting. The current TDM of teicoplanin can help to solve it, diminishing the risk of treatment failure or micobiological resistance to teicoplanin. No conflict of interest." @default.
- W2034896707 created "2016-06-24" @default.
- W2034896707 creator A5009796457 @default.
- W2034896707 creator A5012493171 @default.
- W2034896707 date "2013-03-01" @default.
- W2034896707 modified "2023-09-27" @default.
- W2034896707 title "PHC-022 PRACTICAL USE OF THERAPEUTIC DRUG MONITORING OF TEICOPLANIN" @default.
- W2034896707 doi "https://doi.org/10.1136/ejhpharm-2013-000276.367" @default.
- W2034896707 hasPublicationYear "2013" @default.
- W2034896707 type Work @default.
- W2034896707 sameAs 2034896707 @default.
- W2034896707 citedByCount "0" @default.
- W2034896707 crossrefType "journal-article" @default.
- W2034896707 hasAuthorship W2034896707A5009796457 @default.
- W2034896707 hasAuthorship W2034896707A5012493171 @default.
- W2034896707 hasBestOaLocation W20348967071 @default.
- W2034896707 hasConcept C112705442 @default.
- W2034896707 hasConcept C126322002 @default.
- W2034896707 hasConcept C162156334 @default.
- W2034896707 hasConcept C2776703206 @default.
- W2034896707 hasConcept C2778980435 @default.
- W2034896707 hasConcept C2779489039 @default.
- W2034896707 hasConcept C2780272996 @default.
- W2034896707 hasConcept C2909675724 @default.
- W2034896707 hasConcept C2910800852 @default.
- W2034896707 hasConcept C2911091166 @default.
- W2034896707 hasConcept C3020081911 @default.
- W2034896707 hasConcept C31785415 @default.
- W2034896707 hasConcept C42219234 @default.
- W2034896707 hasConcept C523546767 @default.
- W2034896707 hasConcept C54355233 @default.
- W2034896707 hasConcept C71924100 @default.
- W2034896707 hasConcept C86803240 @default.
- W2034896707 hasConceptScore W2034896707C112705442 @default.
- W2034896707 hasConceptScore W2034896707C126322002 @default.
- W2034896707 hasConceptScore W2034896707C162156334 @default.
- W2034896707 hasConceptScore W2034896707C2776703206 @default.
- W2034896707 hasConceptScore W2034896707C2778980435 @default.
- W2034896707 hasConceptScore W2034896707C2779489039 @default.
- W2034896707 hasConceptScore W2034896707C2780272996 @default.
- W2034896707 hasConceptScore W2034896707C2909675724 @default.
- W2034896707 hasConceptScore W2034896707C2910800852 @default.
- W2034896707 hasConceptScore W2034896707C2911091166 @default.
- W2034896707 hasConceptScore W2034896707C3020081911 @default.
- W2034896707 hasConceptScore W2034896707C31785415 @default.
- W2034896707 hasConceptScore W2034896707C42219234 @default.
- W2034896707 hasConceptScore W2034896707C523546767 @default.
- W2034896707 hasConceptScore W2034896707C54355233 @default.
- W2034896707 hasConceptScore W2034896707C71924100 @default.
- W2034896707 hasConceptScore W2034896707C86803240 @default.
- W2034896707 hasLocation W20348967071 @default.
- W2034896707 hasOpenAccess W2034896707 @default.
- W2034896707 hasPrimaryLocation W20348967071 @default.
- W2034896707 hasRelatedWork W105578021 @default.
- W2034896707 hasRelatedWork W1866260782 @default.
- W2034896707 hasRelatedWork W1965600709 @default.
- W2034896707 hasRelatedWork W1981551849 @default.
- W2034896707 hasRelatedWork W1982606193 @default.
- W2034896707 hasRelatedWork W1997240925 @default.
- W2034896707 hasRelatedWork W2085752562 @default.
- W2034896707 hasRelatedWork W2243288609 @default.
- W2034896707 hasRelatedWork W2259371916 @default.
- W2034896707 hasRelatedWork W2262675695 @default.
- W2034896707 hasRelatedWork W2397268317 @default.
- W2034896707 hasRelatedWork W2406604929 @default.
- W2034896707 hasRelatedWork W2409043949 @default.
- W2034896707 hasRelatedWork W2410217068 @default.
- W2034896707 hasRelatedWork W2413039032 @default.
- W2034896707 hasRelatedWork W2427720416 @default.
- W2034896707 hasRelatedWork W2623240022 @default.
- W2034896707 hasRelatedWork W2725872895 @default.
- W2034896707 hasRelatedWork W3087853835 @default.
- W2034896707 hasRelatedWork W2488896485 @default.
- W2034896707 isParatext "false" @default.
- W2034896707 isRetracted "false" @default.
- W2034896707 magId "2034896707" @default.
- W2034896707 workType "article" @default.